MAPK7 and cancer: Aberrant nuclear ERK5 expression is associated with tumor progression, inhibition of ERK5 has been shown to have therapeutic potential in both cancer and inflammatory diseases, prompting the development of ERK5 kinase inhibitors (ERK5is)62,63.